TrialMedical oncology (Northwood, London, England)2012

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial.

B Walter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.